Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
Although many studies have presented data based on administration of nondepolarizing neuromuscular blocking agents to patients given inhalation anesthesia for 30-45 min, no data exist on the interaction in a clinical situation where the relaxant is administered immediately after the start of anesthesia. We therefore studied the effect of the commonly used inhalation anesthetics, halothane and enflurane, on the clinical pharmacology of atracurium, vecuronium, pipecuronium, and pancuronium. No significant influence of the anesthetic technique on the onset time of the various neuromuscular blocking agents was observed. The duration of action of atracurium, pipecuronium, and pancuronium was significantly prolonged during enflurane anesthesia as compared with the other two anesthetic techniques. The duration of vecuronium blockade was not significantly influenced by enflurane. Halothane, in contrast to enflurane, did not significantly prolong the blockade induced by these agents. The prolongation of atracurium blockade was clinically irrelevant. A fact that is statistically significant but clinically irrelevant is that a cumulative effect with atracurium and vecuronium was only seen during enflurane anesthesia and after the fourth maintenance dose. We conclude that there is no clinical indication that the dosage of atracurium and vecuronium during inhalation anesthesia should be reduced, but the doses of pipecuronium and pancuronium should be reduced when prolonged paralysis is not desired.
Swen
J
J
Department of Anesthesiology, University Hospital Leiden, The Netherlands.
Rashkovsky
O M
OM
Ket
J M
JM
Koot
H W
HW
Hermans
J
J
Agoston
S
S
D000328:Adult; D000368:Aged; D015113:Androstane-3,17-diol / Q000008:administration & dosage / Q000031:analogs & derivatives; D000777:Anesthetics / Q000008:administration & dosage*; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001279:Atracurium / Q000008:administration & dosage; D004347:Drug Interactions; D004737:Enflurane / Q000008:administration & dosage; D006221:Halothane / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage*; D009609:Nitrous Oxide / Q000008:administration & dosage; D010197:Pancuronium / Q000008:administration & dosage; D017300:Pipecuronium; D010879:Piperazines / Q000008:administration & dosage; D014673:Vecuronium Bromide / Q000008:administration & dosage
D000777:Anesthetics; D014150:Antipsychotic Agents; D009466:Neuromuscular Blocking Agents; D010879:Piperazines; D017300:Pipecuronium; D015113:Androstane-3,17-diol; D001279:Atracurium; D014673:Vecuronium Bromide; D004737:Enflurane; D010197:Pancuronium; D009609:Nitrous Oxide; D006221:Halothane